Metabolic activity of primary tumour on PET/CT has a relationship with survival in stages I ‐III small‐cell lung carcinoma

ConclusionPretreatment SUVmax‐PT (median cut‐off 11.6) may have a prognostic value of OS and PFS in patients with TNM staged I‐III SCLC.

Source: The Clinical Respiratory Journal - March 27, 2020 Category: Respiratory Medicine Authors: Özer Özdemir, Özgür Batum, Sinem Ermin, Nimet Aksel, Berna Kömürcüoğlu, Aydan Mertoğlu, Sami Deniz, Günseli Balcı, Hakan Koparal, Engin Özbilek, Ufuk Yılmaz Tags: ORIGINAL ARTICLE Source Type: research